Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that only 60 days remain to file lead plaintiff applications in a securities fraud class action lawsuit against Longtop Financial, Inc. (“Longtop” or the “Company”) (NYSE: LFT). The lawsuit was filed in the United States District Court for the Central District of California on behalf of purchasers of the common stock of Longtop between June 29, 2009 and April 25, 2011, inclusive (the “Class Period”).

What You May Do

If you are a Longtop shareholder and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn ( lewis.kahn@ksfcounsel.com), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations, Neil Rothstein, Esq. ( neil.rothstein@ksfcounsel.com), toll free at 877-694-9510, or via cell phone any time at 330-860-4092. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by July 22, 2011. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. KSF also encourages anyone with information regarding Longtop’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

About the Lawsuit

The complaint charges Longtop and certain of its officers and executives with violations of the Securities Exchange Act of 1934. The lawsuit closely parallels an article by Reuter’s today:

If you liked this article you might like

China Stock 'Halt Parade' Hits A-Power

China Stock 'Halt Parade' Hits A-Power

China-Biotics Auditor Quits, Alleges 'Illegal Acts'

China-Biotics Auditor Quits, Alleges 'Illegal Acts'

Bigtime Investors Lose Big on China

Harbin Electric Shares Cut in Half

Harbin Electric Shares Cut in Half

China-Biotics: Latest RTO Trading Halt

China-Biotics: Latest RTO Trading Halt